Percutaneous liver biopsy is a reliable method used for the diagnosis and follow-up of many liver diseases. Although it is safe, major complications, such as free intraperitoneal bleeding, hemothorax, pneumothorax, hemobilia, and Pseudoaneurysm, have rarely been reported to be related to the procedure. The reported rate of hemobilia after performing percutaneous liver biopsy is approximately 0.06%. This event usually results from a hepatic artery pseudoaneurysm and can potentially cause fatal bleeding. In addition, acute cholecystitis and pancreatitis are rare complications of hemobilia. To the best of our knowledge, we report the third case of a patient who developed hemobilia, acute cholecystitis, and acute pancreatitis from a pseudoaneur...
Percutaneous transhepatic cholangiography (PTC) was performed on a 23-year-old male because of an at...
Background: Hemobilia is a rare cause of upper GI bleeding and the reasons for the majority of the c...
Identifying the presence of hemobilia can be clinically important since it might change the therapeu...
Percutaneous liver biopsy is a reliable method used for the diagnosis and follow-up of many liver di...
Percutaneous liver biopsy (PLB) is a valuable diagnostic tool. Complication rates vary depending on ...
Percutaneous Liver Biopsy is an often-required procedure for the evaluation of multiple liver diseas...
Hemobilia is a term that is used to describe bleeding into the biliary tract. The most common cause ...
A 57-year-old gentleman with a past medical history of well-differentiated pancreatic neuroendocrine...
Outpatient percutaneous liver biopsy is a common practice in the differential diagnosis and treatmen...
Percutaneous liver biopsy is considered one of the most important diagnostic tools to evaluate diffu...
Introduction: Haemobilia is an uncommon entity even though its frequency has increased with hepato-b...
Abstract Background Hemobilia is a rare but lethal biliary tract complication. There are several cau...
Hepatic artery pseudoaneurysm (HAP) is a very rare disease but in cases of complication, there is a ...
Biloma and biliary leak after percutaneous liver biopsy (PLB) are rare. Previous cases are largely i...
Contains fulltext : 79886.pdf (publisher's version ) (Closed access
Percutaneous transhepatic cholangiography (PTC) was performed on a 23-year-old male because of an at...
Background: Hemobilia is a rare cause of upper GI bleeding and the reasons for the majority of the c...
Identifying the presence of hemobilia can be clinically important since it might change the therapeu...
Percutaneous liver biopsy is a reliable method used for the diagnosis and follow-up of many liver di...
Percutaneous liver biopsy (PLB) is a valuable diagnostic tool. Complication rates vary depending on ...
Percutaneous Liver Biopsy is an often-required procedure for the evaluation of multiple liver diseas...
Hemobilia is a term that is used to describe bleeding into the biliary tract. The most common cause ...
A 57-year-old gentleman with a past medical history of well-differentiated pancreatic neuroendocrine...
Outpatient percutaneous liver biopsy is a common practice in the differential diagnosis and treatmen...
Percutaneous liver biopsy is considered one of the most important diagnostic tools to evaluate diffu...
Introduction: Haemobilia is an uncommon entity even though its frequency has increased with hepato-b...
Abstract Background Hemobilia is a rare but lethal biliary tract complication. There are several cau...
Hepatic artery pseudoaneurysm (HAP) is a very rare disease but in cases of complication, there is a ...
Biloma and biliary leak after percutaneous liver biopsy (PLB) are rare. Previous cases are largely i...
Contains fulltext : 79886.pdf (publisher's version ) (Closed access
Percutaneous transhepatic cholangiography (PTC) was performed on a 23-year-old male because of an at...
Background: Hemobilia is a rare cause of upper GI bleeding and the reasons for the majority of the c...
Identifying the presence of hemobilia can be clinically important since it might change the therapeu...